These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 26062442)
1. miR-181c associates with tumor relapse of high grade osteosarcoma. Mori F; Sacconi A; Canu V; Ganci F; Novello M; Anelli V; Covello R; Ferraresi V; Muti P; Biagini R; Blandino G; Strano S Oncotarget; 2015 Jun; 6(16):13946-61. PubMed ID: 26062442 [TBL] [Abstract][Full Text] [Related]
2. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines. Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924 [TBL] [Abstract][Full Text] [Related]
3. miR-92a promotes tumor growth of osteosarcoma by targeting PTEN/AKT signaling pathway. Xiao J; Yu W; Hu K; Li M; Chen J; Li Z Oncol Rep; 2017 Apr; 37(4):2513-2521. PubMed ID: 28260104 [TBL] [Abstract][Full Text] [Related]
4. miRNA expression profile in human osteosarcoma: role of miR-1 and miR-133b in proliferation and cell cycle control. Novello C; Pazzaglia L; Cingolani C; Conti A; Quattrini I; Manara MC; Tognon M; Picci P; Benassi MS Int J Oncol; 2013 Feb; 42(2):667-75. PubMed ID: 23229283 [TBL] [Abstract][Full Text] [Related]
5. miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells. Salah Z; Arafeh R; Maximov V; Galasso M; Khawaled S; Abou-Sharieha S; Volinia S; Jones KB; Croce CM; Aqeilan RI Oncotarget; 2015 Mar; 6(7):4920-35. PubMed ID: 25749032 [TBL] [Abstract][Full Text] [Related]
6. miRNA profiling identifies deregulated miRNAs associated with osteosarcoma development and time to metastasis in two large cohorts. Andersen GB; Knudsen A; Hager H; Hansen LL; Tost J Mol Oncol; 2018 Jan; 12(1):114-131. PubMed ID: 29120535 [TBL] [Abstract][Full Text] [Related]
7. Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma. Zeng H; Zhang Z; Dai X; Chen Y; Ye J; Jin Z Pathol Oncol Res; 2016 Apr; 22(2):253-60. PubMed ID: 26183062 [TBL] [Abstract][Full Text] [Related]
8. miR-491 Inhibits Osteosarcoma Lung Metastasis and Chemoresistance by Targeting αB-crystallin. Wang SN; Luo S; Liu C; Piao Z; Gou W; Wang Y; Guan W; Li Q; Zou H; Yang ZZ; Wang D; Wang Y; Xu M; Jin H; Xu CX Mol Ther; 2017 Sep; 25(9):2140-2149. PubMed ID: 28648665 [TBL] [Abstract][Full Text] [Related]
9. Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response. Gougelet A; Pissaloux D; Besse A; Perez J; Duc A; Dutour A; Blay JY; Alberti L Int J Cancer; 2011 Aug; 129(3):680-90. PubMed ID: 20949564 [TBL] [Abstract][Full Text] [Related]
10. MiRNA profile of osteosarcoma with CD117 and stro-1 expression: miR-1247 functions as an onco-miRNA by targeting MAP3K9. Zhao F; Lv J; Gan H; Li Y; Wang R; Zhang H; Wu Q; Chen Y Int J Clin Exp Pathol; 2015; 8(2):1451-8. PubMed ID: 25973030 [TBL] [Abstract][Full Text] [Related]
11. miR-590-3p is a novel microRNA which suppresses osteosarcoma progression by targeting SOX9. Wang WT; Qi Q; Zhao P; Li CY; Yin XY; Yan RB Biomed Pharmacother; 2018 Nov; 107():1763-1769. PubMed ID: 30257395 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-190b inhibits tumor cell proliferation and induces apoptosis by regulating Bcl-2 in U2OS osteosarcoma cells. Kang M; Xia P; Hou T; Qi Z; Liao S; Yang X Pharmazie; 2017 May; 72(5):279-282. PubMed ID: 29441873 [TBL] [Abstract][Full Text] [Related]
13. Identification of a novel miRNA-target gene regulatory network in osteosarcoma by integrating transcriptome analysis. He C; Gao H; Fan X; Wang M; Liu W; Huang W; Yang Y Int J Clin Exp Pathol; 2015; 8(7):8348-57. PubMed ID: 26339404 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-145 inhibits tumour growth and metastasis in osteosarcoma by targeting cyclin-dependent kinase, CDK6. Li Y; Liu J; Liu ZZ; Wei WB Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5117-5125. PubMed ID: 28051259 [TBL] [Abstract][Full Text] [Related]
15. An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets. Hill KE; Kelly AD; Kuijjer ML; Barry W; Rattani A; Garbutt CC; Kissick H; Janeway K; Perez-Atayde A; Goldsmith J; Gebhardt MC; Arredouani MS; Cote G; Hornicek F; Choy E; Duan Z; Quackenbush J; Haibe-Kains B; Spentzos D J Hematol Oncol; 2017 May; 10(1):107. PubMed ID: 28506242 [TBL] [Abstract][Full Text] [Related]
16. VEGF-mediated suppression of cell proliferation and invasion by miR-410 in osteosarcoma. Zhao D; Jia P; Wang W; Zhang G Mol Cell Biochem; 2015 Feb; 400(1-2):87-95. PubMed ID: 25385479 [TBL] [Abstract][Full Text] [Related]
17. The tumor suppressor miR-124 inhibits cell proliferation and invasion by targeting B7-H3 in osteosarcoma. Wang L; Kang FB; Sun N; Wang J; Chen W; Li D; Shan BE Tumour Biol; 2016 Nov; 37(11):14939-14947. PubMed ID: 27644254 [TBL] [Abstract][Full Text] [Related]
18. Tumor-suppressive microRNA-let-7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells. Iwasaki T; Tanaka K; Kawano M; Itonaga I; Tsumura H Int J Oncol; 2015 Apr; 46(4):1543-50. PubMed ID: 25647078 [TBL] [Abstract][Full Text] [Related]
19. The downregulation of miR-144 is associated with the growth and invasion of osteosarcoma cells through the regulation of TAGLN expression. Zhao M; Huang J; Gui K; Xiong M; Cai G; Xu J; Wang K; Liu D; Zhang X; Yin W Int J Mol Med; 2014 Dec; 34(6):1565-72. PubMed ID: 25318625 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7. Bao Y; Chen B; Wu Q; Hu K; Xi X; Zhu W; Zhong X; Chen J Clin Exp Med; 2017 Feb; 17(1):51-58. PubMed ID: 26515813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]